Home | Site map | Elsevier websites | Alerts
Elsevier
Product information search
Search all Elsevier sites
Search
Advanced Product Search
Go to Elsevier home page
Products
Brain & Development
Journal information
Product description
Editorial board
Audience
Abstracting/indexing
Subscription information
Bibliographic and ordering information
Conditions of sale
Dispatch dates
Journal-related information
Most downloaded articles
Other journals in same subject area
Support & contact
About Elsevier
Select your view
SiteStat.jsp
BRAIN & DEVELOPMENT
Official Journal of the Japanese Society of Child Neurology

Guide for Authors

Submissions considered for publication in Brain & Development are received on the understanding that they have not been accepted for publication elsewhere and that all of the authors agree to the submission.

Submission of manuscripts
Brain and Development now proceeds totally online via an online submission system. Mail submissions will not be accepted after 31 March 2005. In case you do not have an Internet connection, please contact the Editor-in-Chief for alternative instructions. By accessing the online submission via Elsevier Editorial System, External link http://ees.elsevier.com/bradev you will be guided stepwise through the creation and uploading of the various files. When submitting a manuscript online, authors need to provide an electronic version of their manuscript and any accompanying figures and tables.

The author should select from a list of scientific classifications, which will be used to help the editors select reviewers with appropriate expertise, and an article type for their manuscript. Once the uploading is done, the system automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the Editor's decision and request for revisions, will be processed through the system and will reach the corresponding author by e-mail.

Once a manuscript has successfully been submitted via the online submission system authors may track the status of their manuscript using the online submission system (details will be provided by e-mail). If your manuscript is accepted by the journal, subsequent tracking facilities are available on Elsevier's Author Gateway, using the unique reference number provided by Elsevier and corresponding author name (details will be provided by e-mail).

Authors may send queries concerning the submission process or journal procedures to the Central Editorial Office: Makiko Kaga, Editor-in-Chief: bradev@ncnp.go.jp.

For further details on how to submit online, please refer to the online EES Tutorial for authors or contact Elsevier's Author Support Team at authorsupport@elsevier.com.

Material for publication

Original Articles
These may describe original clinical or laboratory research.

Reviews
Reviews may concern either clinical or laboratory scientific topics. Relatively brief reviews of between 2,500 and 3,000 words are particularly welcome. Longer reviews are acceptable when justified by topic and comprehensiveness.

Communications
These should deal with scientific material of top priority deserving rapid publication, and should be less than 1,000 words, with a total of no more than 3 tables and figures plus up to 10 references.

Case Reports
A case report should describe a new disease, or confirmation of a rare or new disease; a new insight into pathogenesis, etiology, diagnosis, or treatment; or a new finding associated with a currently known disease. A report of special scientific investigation, even in a single patient, will be regarded as an original article. The length should ordinarily be less than 1,000 words, with no more than a total of 3 tables and figures and 10 references. This can be exceeded only when justified by extensive special studies.

Letters to the Editor
These should be up to 300 words in length, and should be submitted in response to material published in the journal to make small clinical points or to introduce a point of view. They can be accompanied by up to 5 references but no illustrations. Letters do not carry an abstract.

Proceedings of Meetings
Full manuscripts or abstracts of papers presented at scientific meetings shall be considered for publication as Proceedings in the form either of a supplementary volume, a special issue, or as a section in an issue. Publication will be at the discretion of the editors. Printing costs should be borne by the contributor.

As an approximate guide to authors judging the length of their paper, the following estimation may be used: 3 typewritten A4 pages = 1 printed page; 3 'average' figures + legends = 1 printed page; 3 'average' tables = 1 printed page; 35 references = 1 printed page.

Manuscript format
The manuscript should be set out with the following sections beginning on a new page:

(i) Title page (title taking up to 80 spaces; full names and affiliations of all cited authors with the surname in uppercase letters; corresponding author's name, full mailing address, fax number, and email address; present address of authors where appropriate);
(ii) Abstract and 3-9 key words;
(iii) Text and acknowledgments;
(iv) References;
(v) Figure legends;
(vi) Tables with their legends.

The surname of the authors should be clearly indicated by uppercase.

Abstracts for original articles or reviews should be approximately 250 words long; case reports and communications may be shorter. The abstract should summarize the methods, results and conclusions of the article.

In general, manuscripts should be prepared according to the guidelines produced by the International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts Submitted to Biomedical Journals. JAMA 1997;269:927-934.

Language
Only English articles will be accepted. Authors whose native language is not English should enlist the help of colleagues who are proficient in scientific English.

Ethics
For all manuscripts dealing with experimental work involving human subjects, specify that informed consent was obtained following a full explanation of the procedure(s) undertaken. Patients should be referred to by number; do not use real names, initials or hospital numbers. Also, the design of special scientific research in human diseases or of animal experiments should be approved by the ethical committee of the institution or conform to guidelines on animal care and use currently applied in the country of origin.

References
References to literature must be indicated by Arabic numerals in square parentheses which run consecutively through the paper. Where a reference is cited more than once in the text the same number should be used each time. Reference style should follow the "Vancouver" style described in the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (published in N Engl J Med 1997;336:309-315). The titles of journals should be abbreviated according to the style used in Index Medicus.

Exceptions:
(1) List all authors or editors, but if there are more thn six list first six plus et al.;
(2) Full first and last page numbers of articles should be provided. Unpublished data and personal communications should be given in round parentheses in the text and not as references.

Japanese journals should appear with the full Japanese name in Roman letters, e.g. No To Hattatsu. To refer to a book or journal article written in Japanese, the phrase "(in Japanese)" should be added after the title of the book or article.

Examples of journals
[1] Tatsuno M, Hasegawa M, Iwasaki, J, Saito Y. Color Doppler flow imaging of CSF flow in infants with intracranial hemorrhage. Brain Dev 1993;15:333-9.
[2] Elia M, Musumeci SA, Ferri R, Colamaria V, Azan G, Greco D, et al. Leigh syndrome and partial deficit of cytochrome c oxidase associated with epilepsia partialis continua. Brain Dev 1996;18:207-11.

Journal article in Japanese
[3] Saitoh S. DNA-based diagnosis of Angelman syndrome and Prader-Willi syndrome (in Japanese). No To Hattatsu (Tokyo) 1993;25:501-7.

Examples of books and other monographs

Personal author(s)
[4] Fenichel GM. Clinical pediatric neurology. A signs and symptoms approach. 2nd ed. Philadelphia: Saunders; 1993.

Editor(s), compiler(s)
[5] Segawa M, editor. Hereditary progressive dystonia with marked diurnal fluctuation. New York: Parthenon; 1993.

Chapter in a book
[6] Sarnat HB. Cerebral plasticity in embryological development. In: Fukuyama Y, Suzuki Y, Kamoshita S, Casaer P, editors. Fetal and perinatal neurology. Basel: Karger; 1992. p. 118-31.

Japanese book
[7] Kamoshita S, Nihei K, Miyao M, eds. Physical examination of the nervous system in children (in Japanese). Tokyo: Nankodo; 1993.

Figures and Photographs
Figures and Photographs of good quality should be submitted online as a separate file. Please use a lettering that remains clearly readable even after reduction to about 66%. For every figure or photograph, a legend should be provided. All authors wishing to use illustrations already published must first obtain the permission of the author and publisher and/or copyright holders and give precise reference to the original work. This permission must include the right to publish in electronic media.

Tables
Tables should be numbered consecutively with Arabic numerals and must be cited in the text in sequence. Each table, with an appropriate brief legend, comprehensible without reference to the text, should be typed on a separate page and uploaded online. Tables should be kept as simple as possible and wherever possible a graphical representation used instead. Table titles should be complete but brief. Information other than that defining the data should be presented as footnotes.

Please refer to the generic Elsevier artwork instructions: External link http://www.elsevier.com/artworkinstructions.

Colour reproduction
Brain & Development is now also included in a new initiative from Elsevier: 'Colourful e-Products'. Through this initiative, figures that appear in black & white in print can appear in colour, online, in ScienceDirect at External link http://www.sciencedirect.com. There is no extra charge for authors who participate.

For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for colour in print or on the Web only. Because of technical complications which can arise by converting colour figures to "grey scale" (for the printed version should you not opt for colour in print) please submit in addition usable black and white versions of all the colour illustrations. For further information on the preparation of electronic artwork, please see External link http://www.elsevier.com/artworkinstructions.

Copyright Transfer
Upon acceptance of an article, you will be asked to transfer copyright (for more information on copyright see External link http://www.elsevier.com/locate/copyright. This transfer will ensure the widest possible dissemination of information. If excerpts from other copyrighted works are included in the submission, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier's Rights Department, Philadelphia, PA, USA: phone (+1) 215 238 7869, fax (+1) 215 238 2239, e-mail healthpermissions@elsevier.com. Requests for materials from other Elsevier publications may also be completed on-line via the Elsevier homepage External link http://www.elsevier.com/locate/permissions.

Proofs
Proofs are sent to the corresponding author; together with a reprint order form and copyright transfer form. Authors should retain a copy of the original manuscript. Only printer's errors may be corrected; no changes in, or additions to, the edited manuscript will be allowed at this stage, unless in reply to specific editorial queries or requests. Corrected proofs must be returned within 48 hours of receipt, preferably by fax. Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication. Subsequent corrections will not be possible, so please ensure your first sending is complete. The reprint order form (with number of reprints requested, invoice and delivery address) and the copyright transfer form (signed) should be returned with the corrected proof. If the Publisher has not received a reply after 15 days, the assumption will be made that there are no errors to correct, and the article will be published after in-house correction.

Reprints
A total of 25 reprints of each paper will be provided free of charge to the corresponding author. Additional copies can be ordered at prices shown on the reprint order form, and should be returned with the corrected proofs. Reprints ordered after the print run has been completed will be subject to a higher charge.
Printer-friendly version   Printer-friendly version
 Home | Site map | Privacy policy | Terms and Conditions | Feedback | A Reed Elsevier company
 Copyright © 2007 Elsevier B.V. All rights reserved.